Library Open Repository

Airway remodelling in smokers with or without chronic obstructive pulmonary disease (COPD) and the effects of inhaled corticosteroids on remodelling in COPD


Downloads per month over past year

Soltani Abhari, A (2010) Airway remodelling in smokers with or without chronic obstructive pulmonary disease (COPD) and the effects of inhaled corticosteroids on remodelling in COPD. PhD thesis, University of Tasmania.

PDF (Front matter)
Amir_Soltani-01...pdf | Download (92kB)
Available under University of Tasmania Standard License.

[img] PDF (Whole thesis)
whole-5.pdf | Download (3MB)
Available under University of Tasmania Standard License.

[img] PDF (Chapter 5)
Amir_Soltani-06...pdf | Request a copy
Full text restricted until 2112.
Available under University of Tasmania Standard License.


Introduction: Smoking-related COPD is a worldwide health problem. Airway remodelling is defined as structural changes occurring in chronic inflammatory diseases of the airways. Our knowledge about airway remodelling in COPD is very limited. My preliminary observational study of bronchial biopsies (BB) from COPD subjects revealed reticular basement membrane (Rbm) fragmentation and vascular changes. I hypothesised that these changes are specific for COPD and are related to the angiogenic activity of vascular endothelial growth factor (VEGF) and transforming growth factor-ß (TGF-ß). I also aimed to study the effects of inhaled corticosteroids (ICS) on these airway changes. Methods: A cross-sectional study compared BB from current smokers with COPD (SCOPD), ex-smokers with COPD (ES-COPD), current smokers with normal lung function (S-N) and healthy nonsmoking (H-N) subjects. BB were stained with anti- Collagen IV, anti-VEGF and anti-TGF- ß antibodies. Rbm fragmentation and vessels in the Rbm and lamina propria (LP) were measured. Anti-Factor VIII antibody was compared with anti-Collagen IV antibody in detecting vessels. Then a double-blind, randomized and placebo controlled study assessed the effects of ICS on airway remodeling, VEGF and TGF- ß in COPD. Results: Airway remodelling changes were also detectable in S-N. The Rbm was fragmented. The length of splits was significantly greater in both COPD groups and in S-N than controls (p<0.02). The Rbm was hypervascular and the LP hypovascular in current smokers compared with controls (p<0.05). Vessels stained for VEGF and TGF-ß were increased in the Rbm of both COPD groups and S-N (p<0.05). Factor VIII antibody confirmed my finding of hypovascularity of the LP in S-COPD. ICS reversed Rbm splitting but did not have any effect on vessel remodelling and angiogenic activities. Discussion: My studies revealed novel aspects of Rbm and vascular remodelling in BB from COPD subjects and S-N and for the first time showed that ICS are effective on Rbm changes in COPD. Rbm fragmentation, we think, is probably a consequence of the effects of proteolytic enzymes on the Rbm due to activation of epithelial-mesenchymal transition (EMT) by smoking. This is under more investigation in our group. My study could not explain the mechanisms to vessel changes in current smokers. Further studies to examine the role of other angiogenic/antiangiogenic factors are now needed. Absence of vascular changes in ES-COPD subjects may imply that vascular remodelling is reversible with smoking cessation, but to test this we need a longitudinal smoking cessation study.

Item Type: Thesis (PhD)
Keywords: airway remodelling, angiogenesis, COPD, smoking, corticosteroids, controlled trial, bronchial biopsy, VEGF
Additional Information: Copyright © the Author. The publishers of the paper comprising Chapter Five hold the copyright for that content and access to the material should be sought from the respective journal ( Respirator Research is an open access journal and available at: http://respiratoryresearch. com/content/11/1/105). The remaining nonpublished content of the thesis may be made available for loan and limited copying in accordance with the Copyright Act 1968.Copying of any part of this thesis is prohibited for two years from the date this statement was signed; after that time limited copying is permitted in accordance with the copyright act 1968. Amir Soltani
Date Deposited: 09 May 2011 22:34
Last Modified: 11 Mar 2016 05:53
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page